Tumor Profiling at the Service of Cancer Therapy

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Jan 28

PMID 33505911

Citations 5

Authors

Ceres Fernandez-Rozadilla

Ana Rita Simoes

Matilde E LLeonart

Amancio Carnero

Angel Carracedo

Affiliations

Soon will be listed here.

Abstract

Cancer treatment options have evolved significantly in the past few years. From the initial surgical procedures, to the latest next-generation technologies, we are now in the position to analyze and understand tumors in a one-by-one basis and use that to our advantage to provide with individualized treatment options that may increase patient survival. In this review, we will focus on how tumor profiling has evolved over the past decades to deliver more efficient and personalized treatment options, and how novel technologies can help us envisage the future of precision oncology toward a better management and, ultimately, increased survival.

Citing Articles

Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.

Bartsch R, Rinnerthaler G, Petru E, Egle D, Gnant M, Balic M Wien Klin Wochenschr. 2023; 136(11-12):347-361.

PMID: 37682349 PMC: 11156740. DOI: 10.1007/s00508-023-02254-9.

Advancing Precision Medicine in South Tyrol, Italy: A Public Health Development Proposal for a Bilingual, Autonomous Province.

Wiedermann C J Pers Med. 2023; 13(6).

PMID: 37373961 PMC: 10301453. DOI: 10.3390/jpm13060972.

Cancer Cell Culture: The Basics and Two-Dimensional Cultures.

Tutty M, Holmes S, Prina-Mello A Methods Mol Biol. 2023; 2645:3-40.

PMID: 37202610 DOI: 10.1007/978-1-0716-3056-3_1.

Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies.

Meng Y, Sun J, Zheng Y, Zhang G, Yu T, Piao H Onco Targets Ther. 2021; 14:3417-3428.

PMID: 34079287 PMC: 8164876. DOI: 10.2147/OTT.S311907.

Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon.

Darrigues E, Elberson B, De Loose A, Lee M, Green E, Benton A Front Oncol. 2021; 11:662260.

PMID: 33981610 PMC: 8108694. DOI: 10.3389/fonc.2021.662260.

References

Ventura R, Martin-Subero J, Jones M, McParland J, Gesk S, Mason D . FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006; 8(2):141-51. PMC: 1867591. DOI: 10.2353/jmoldx.2006.050083. View

Antognelli C, Ferri I, Bellezza G, Siccu P, Love H, Talesa V . Glyoxalase 2 drives tumorigenesis in human prostate cells in a mechanism involving androgen receptor and p53-p21 axis. Mol Carcinog. 2017; 56(9):2112-2126. DOI: 10.1002/mc.22668. View

Ghandi M, Huang F, Jane-Valbuena J, Kryukov G, Lo C, McDonald 3rd E . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019; 569(7757):503-508. PMC: 6697103. DOI: 10.1038/s41586-019-1186-3. View

Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

Arruebo M, Vilaboa N, Saez-Gutierrez B, Lambea J, Tres A, Valladares M . Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 2013; 3(3):3279-330. PMC: 3759197. DOI: 10.3390/cancers3033279. View

Lawrence M, Stojanov P, Polak P, Kryukov G, Cibulskis K, Sivachenko A . Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013; 499(7457):214-218. PMC: 3919509. DOI: 10.1038/nature12213. View

Cieslik M, Chinnaiyan A . Cancer transcriptome profiling at the juncture of clinical translation. Nat Rev Genet. 2017; 19(2):93-109. DOI: 10.1038/nrg.2017.96. View

Huang F, Hodis E, Xu M, Kryukov G, Chin L, Garraway L . Highly recurrent TERT promoter mutations in human melanoma. Science. 2013; 339(6122):957-9. PMC: 4423787. DOI: 10.1126/science.1229259. View

Mueller C, Haymond A, Davis J, Williams A, Espina V . Protein biomarkers for subtyping breast cancer and implications for future research. Expert Rev Proteomics. 2017; 15(2):131-152. PMC: 6104835. DOI: 10.1080/14789450.2018.1421071. View

10.

Wiegand K, Shah S, Al-Agha O, Zhao Y, Tse K, Zeng T . ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010; 363(16):1532-43. PMC: 2976679. DOI: 10.1056/NEJMoa1008433. View

11.

Cree I, Deans Z, Ligtenberg M, Normanno N, Edsjo A, Rouleau E . Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol. 2014; 67(11):923-31. PMC: 4215286. DOI: 10.1136/jclinpath-2014-202404. View

12.

Issa J . CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004; 4(12):988-93. DOI: 10.1038/nrc1507. View

13.

Dye E, NORTH R, Mills C . Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations. J Exp Med. 1981; 154(3):609-20. PMC: 2186476. DOI: 10.1084/jem.154.3.609. View

14.

Chen Z, Sun T, Yang Z, Zheng Y, Yu R, Wu X . Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling. Mol Genet Genomic Med. 2019; 8(2):e1079. PMC: 7005625. DOI: 10.1002/mgg3.1079. View

15.

Saghafinia S, Mina M, Riggi N, Hanahan D, Ciriello G . Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors. Cell Rep. 2018; 25(4):1066-1080.e8. DOI: 10.1016/j.celrep.2018.09.082. View

16.

Lee Y, Tan Y, Oon C . Molecular targeted therapy: Treating cancer with specificity. Eur J Pharmacol. 2018; 834:188-196. DOI: 10.1016/j.ejphar.2018.07.034. View

17.

Toyota M, Ahuja N, Suzuki H, Itoh F, Imai K, Baylin S . Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999; 59(21):5438-42. View

18.

Fraser M, Sabelnykova V, Yamaguchi T, Heisler L, Livingstone J, Huang V . Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017; 541(7637):359-364. DOI: 10.1038/nature20788. View

19.

Conley B, Staudt L, Takebe N, Wheeler D, Wang L, Cardenas M . The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study. J Natl Cancer Inst. 2020; 113(1):27-37. PMC: 7781457. DOI: 10.1093/jnci/djaa061. View

20.

Pathak A, Tanwar S, Kumar V, Banarjee B . Present and Future Prospect of Small Molecule & Related Targeted Therapy Against Human Cancer. Vivechan Int J Res. 2019; 9(1):36-49. PMC: 6407887. View